1/17/24 17:31 | 1/16/24 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Rawcliffe Adrian | X0 | DO | CEO | S.m | -28 | 0.7006 | 0 | -39 | -47 | 45 | D | | | | | | | | | | | | | | |
1/12/24 17:00 | 1/11/24 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Rawcliffe Adrian | X0 | DO | CEO | S.m | -25 | 0.8470 | 0 | -29 | -53 | 26 | D | | | | | | | | | | | | | | |
9/1/23 19:00 | 9/1/23 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Rawcliffe Adrian | X0 | DO | CEO | S | -2 | 0.7800 | 0 | -2 | -41 | 3 | D | | | | | | | | | | | | | | |
6/27/23 21:15 | 6/27/23 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Rawcliffe Adrian | X0 | DO | CEO | S | -2 | 0.9200 | 0 | -2 | -40 | 4 | D | | | | | | | | | | | | | | |
1/17/23 21:15 | 1/17/23 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Rawcliffe Adrian | X0 | DO | CEO | S | -19 | 1.86 | 0 | -10 | -43 | 13 | D | | | | | | | | | | | | | | |
1/12/23 21:00 | 1/11/23 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Rawcliffe Adrian | X0 | DO | CEO | S.m | -55 | 1.72 | 0 | -32 | -56 | 25 | D | | | | | | | | | | | | | | |
1/4/23 21:00 | 1/4/23 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Rawcliffe Adrian | X0 | DO | CEO | S | -9 | 1.69 | 0 | -5 | -43 | 7 | D | | | | | | | | | | | | | | |
9/1/22 21:00 | 9/1/22 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Rawcliffe Adrian | X0 | DO | CEO | S | -5 | 1.97 | 0 | -3 | -43 | 3 | D | | | | | | | | | | | | | | |
6/27/22 21:01 | 6/27/22 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Rawcliffe Adrian | X0 | DO | CEO | S | -4 | 1.63 | 0 | -3 | -44 | 3 | D | | | | | | | | | | | | | | |
1/18/22 21:00 | 1/18/22 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Rawcliffe Adrian | X0 | DO | CEO | S | -35 | 3.19 | 0 | -11 | -47 | 12 | D | | | | | | | | | | | | | | |
1/13/22 21:01 | 1/11/22 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Rawcliffe Adrian | X0 | DO | CEO | S.m | -62 | 3.55 | 0 | -17 | -84 | 3 | D | | | | | | | | | | | | | | |
1/5/22 21:04 | 1/4/22 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Rawcliffe Adrian | X0 | DO | CEO | S | -22 | 4.06 | 0 | -6 | -47 | 6 | D | | | | | | | | | | | | | | |
9/1/21 21:00 | 9/1/21 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Rawcliffe Adrian | X0 | DO | CEO | S | -14 | 5.20 | 0 | -3 | -48 | 3 | D | | | | | | | | | | | | | | |
6/28/21 21:01 | 6/28/21 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Rawcliffe Adrian | X0 | DO | CEO | S | -12 | 4.37 | 0 | -3 | -48 | 3 | D | | | | | | | | | | | | | | |
1/19/21 21:00 | 1/19/21 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Rawcliffe Adrian | X0 | DO | CEO | S | -56 | 5.67 | 0 | -10 | -42 | 14 | D | | | | | | | | | | | | | | |
1/12/21 21:00 | 1/12/21 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Rawcliffe Adrian | X0 | DO | CEO | S | -17 | 6.15 | 0 | -3 | -42 | 4 | D | | | | | | | | | | | | | | |
1/5/21 21:00 | 1/4/21 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Rawcliffe Adrian | X0 | DO | CEO | S | -26 | 5.33 | 0 | -5 | -42 | 7 | D | | | | | | | | | | | | | | |
9/2/20 21:00 | 9/1/20 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Rawcliffe Adrian | X0 | DO | CEO | S | -24 | 8.51 | 0 | -3 | -47 | 3 | D | | | | | | | | | | | | | | |
8/4/20 21:01 | 8/3/20 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Rawcliffe Adrian | X0 | DO | CEO | S | -26 | 9.25 | 0 | -3 | -48 | 3 | D | | | | | | | | | | | | | | |
1/15/20 20:01 | 1/14/20 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Rawcliffe Adrian | X0 | DO | CEO | S | -17 | 5.13 | 0 | -3 | -51 | 3 | D | | | | | | | | | | | | | | |
1/7/20 20:00 | 1/6/20 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Rawcliffe Adrian | PA | DO | CEO | S | -7 | 1.20 | 0 | -6 | -50 | 6 | D | | | | | | | | | | | | | | |
1/16/19 21:30 | 1/14/19 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Rawcliffe Adrian | PA | O | CFO | S | -17 | 5.37 | 0 | -3 | -48 | 3 | D | | | | | | | | | | | | | | |
3/22/18 21:01 | 3/20/18 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Rawcliffe Adrian | PA | O | CFO | S | -1,026 | 1.71 | 0 | -600 | -100 | 0 | D | | | | | | | | | | | | | | |